Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TAFAMIDIS vs TALAZOPARIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TAFAMIDIS vs TALAZOPARIB: Safety Overview

Metric TAFAMIDIS TALAZOPARIB
Total FAERS Reports 9,202 1,477
Deaths Reported 3,343 278
Death Rate 36.3% 18.8%
Hospitalizations 2,284 553
Average Patient Age 80.7 yrs 60.1 yrs
% Female Patients 20.7% 55.7%
FDA Approval Date May 3, 2019 Jun 20, 2023
Manufacturer Pfizer Laboratories Div Pfizer Inc Pfizer Laboratories Div Pfizer Inc
Route N/A ORAL
Marketing Status Prescription Discontinued